NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1034638863|ref|XP_016863366|]
View 

glutamyl aminopeptidase isoform X1 [Homo sapiens]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
1-182 7.16e-106

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 326.07  E-value: 7.16e-106
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRD 80
Cdd:cd09601   257 MENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWD 336
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  81 QMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSD 160
Cdd:cd09601   337 QFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDD 416
                         170       180
                  ....*....|....*....|....*.
gi 1034638863 161 FWAALEEAS----RLPVKEVMDTWTR 182
Cdd:cd09601   417 LWEALQEASgeskPLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
258-576 6.22e-97

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 298.80  E-value: 6.22e-97
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 258 FLKINPDHIGFYRVNYEVATWDSIATALslNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRV 337
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 338 ISAVTYIISMFEDDKElYPMIEEYFQGQVKPIADSLGWNDAG--DHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLN 415
Cdd:pfam11838  79 LSQLSTLRSLLSADPE-YEALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 416 GTVSLPVNLRLLVYRYGMQNsGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTV 495
Cdd:pfam11838 158 GDDAIPPDLRWAVYCAAVAN-GGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDLRAV 236
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 496 IRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNrNLGRIVT-IAEPFNTELQLWQMESFFAKYPQAGAgEKPREQVLETV 574
Cdd:pfam11838 237 IAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKgLTPSFSTEEELDEVEAFFADKDTPGL-RRALAQALETI 314

                  ..
gi 1034638863 575 KN 576
Cdd:pfam11838 315 RR 316
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
1-182 7.16e-106

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 326.07  E-value: 7.16e-106
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRD 80
Cdd:cd09601   257 MENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWD 336
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  81 QMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSD 160
Cdd:cd09601   337 QFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDD 416
                         170       180
                  ....*....|....*....|....*.
gi 1034638863 161 FWAALEEAS----RLPVKEVMDTWTR 182
Cdd:cd09601   417 LWEALQEASgeskPLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
258-576 6.22e-97

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 298.80  E-value: 6.22e-97
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 258 FLKINPDHIGFYRVNYEVATWDSIATALslNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRV 337
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 338 ISAVTYIISMFEDDKElYPMIEEYFQGQVKPIADSLGWNDAG--DHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLN 415
Cdd:pfam11838  79 LSQLSTLRSLLSADPE-YEALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 416 GTVSLPVNLRLLVYRYGMQNsGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTV 495
Cdd:pfam11838 158 GDDAIPPDLRWAVYCAAVAN-GGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDLRAV 236
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 496 IRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNrNLGRIVT-IAEPFNTELQLWQMESFFAKYPQAGAgEKPREQVLETV 574
Cdd:pfam11838 237 IAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKgLTPSFSTEEELDEVEAFFADKDTPGL-RRALAQALETI 314

                  ..
gi 1034638863 575 KN 576
Cdd:pfam11838 315 RR 316
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
1-180 9.61e-92

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 281.48  E-value: 9.61e-92
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRD 80
Cdd:pfam01433  39 MENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWE 118
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  81 QMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSD 160
Cdd:pfam01433 119 QFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTED 198
                         170       180
                  ....*....|....*....|.
gi 1034638863 161 FWAALEEAS-RLPVKEVMDTW 180
Cdd:pfam01433 199 LWDALSEASgPLDVDSFMDTW 219
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
1-329 8.45e-62

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 215.28  E-value: 8.45e-62
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYREtNLLYDpKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHA--ETDWQM 78
Cdd:COG0308   264 MENQGLVTFGE-KVLAD-ETATDADYERRESVIAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLygKDAADR 341
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  79 RDQMLLEDVLPVQedDSLMSSHPIIVTvtTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKT 158
Cdd:COG0308   342 IFVGALRSYAFAE--DAGPNAHPIRPD--DYPEIENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATT 417
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 159 SDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNiTQKRFLLDPRANPSQPpsdlgYTWNIPVK--WTEDNITSSV 236
Cdd:COG0308   418 EDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYD-ADGKVTLTLRQTPPRP-----HPFHIPLEvgLLGGKLTART 491
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 237 LFNRSEKEGItlnssnpsgnaflKINPDHIGFYRVNYEVATWDSIATAlslnhktfsSADRASLIDDAFALARAQLLDYK 316
Cdd:COG0308   492 VLLDGEQTEL-------------VAKPDPVLLLRLDDELAFLLAHDSD---------PFNRWEALQALWRDGEADYLDAL 549
                         330
                  ....*....|...
gi 1034638863 317 VALNLTKYLKREE 329
Cdd:COG0308   550 RALADTDPAVRAE 562
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
1-190 3.32e-42

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 162.65  E-value: 3.32e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYREtNLLYDPKESASSNQQRVATVvAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFL------GVNHAET 74
Cdd:TIGR02412 261 MENAGCVTFAE-NFLHRAEATRAEKENRAGVI-LHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLasaeatEYTDAWT 338
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  75 DW--QMRDQMLLEDVLPvqeddslmSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQ 152
Cdd:TIGR02412 339 TFaaQGKQWAYEADQLP--------TTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHA 410
                         170       180       190
                  ....*....|....*....|....*....|....*...
gi 1034638863 153 FKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLN 190
Cdd:TIGR02412 411 FGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLT 448
pepN PRK14015
aminopeptidase N; Provisional
1-204 2.54e-13

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 73.24  E-value: 2.54e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLityretNL------LYDPkESAS-SNQQRVATVVAHELVHQWFGNIVTM-DWWEdLWLNEGFASFfeflgvnha 72
Cdd:PRK14015  268 MENKGL------NIfnskyvLADP-ETATdADYERIESVIAHEYFHNWTGNRVTCrDWFQ-LSLKEGLTVF--------- 330
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  73 etdwqmRDQMLLEDVL--PVQ--------------EDDSLMSsHPIivtvtTPD---EI-----TSVfdgisYSKGSSIL 128
Cdd:PRK14015  331 ------RDQEFSADLGsrAVKriedvrvlraaqfaEDAGPMA-HPV-----RPDsyiEInnfytATV-----YEKGAEVI 393
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1034638863 129 RMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMdTWTRQMGYPVLNVNGVKNITQKRFLL 204
Cdd:PRK14015  394 RMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLSQFR-RWYSQAGTPRVTVSDEYDAAAGTYTL 468
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
1-182 7.16e-106

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 326.07  E-value: 7.16e-106
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRD 80
Cdd:cd09601   257 MENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLAVDKLFPEWNMWD 336
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  81 QMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSD 160
Cdd:cd09601   337 QFVVDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDD 416
                         170       180
                  ....*....|....*....|....*.
gi 1034638863 161 FWAALEEAS----RLPVKEVMDTWTR 182
Cdd:cd09601   417 LWEALQEASgeskPLDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
258-576 6.22e-97

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 298.80  E-value: 6.22e-97
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 258 FLKINPDHIGFYRVNYEVATWDSIATALslNHKTFSSADRASLIDDAFALARAQLLDYKVALNLTKYLKREENFLPWQRV 337
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 338 ISAVTYIISMFEDDKElYPMIEEYFQGQVKPIADSLGWNDAG--DHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLN 415
Cdd:pfam11838  79 LSQLSTLRSLLSADPE-YEALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAWLD 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 416 GTVSLPVNLRLLVYRYGMQNsGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLKDTNLIKTQDVFTV 495
Cdd:pfam11838 158 GDDAIPPDLRWAVYCAAVAN-GGEAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDLRAV 236
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 496 IRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNrNLGRIVT-IAEPFNTELQLWQMESFFAKYPQAGAgEKPREQVLETV 574
Cdd:pfam11838 237 IAGLASNPAGRDLAWDFVKENWDALVKRLGGGS-SLGRLVKgLTPSFSTEEELDEVEAFFADKDTPGL-RRALAQALETI 314

                  ..
gi 1034638863 575 KN 576
Cdd:pfam11838 315 RR 316
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
1-180 9.61e-92

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 281.48  E-value: 9.61e-92
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRD 80
Cdd:pfam01433  39 MENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWFGNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWE 118
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  81 QMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSD 160
Cdd:pfam01433 119 QFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTED 198
                         170       180
                  ....*....|....*....|.
gi 1034638863 161 FWAALEEAS-RLPVKEVMDTW 180
Cdd:pfam01433 199 LWDALSEASgPLDVDSFMDTW 219
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
1-329 8.45e-62

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 215.28  E-value: 8.45e-62
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYREtNLLYDpKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHA--ETDWQM 78
Cdd:COG0308   264 MENQGLVTFGE-KVLAD-ETATDADYERRESVIAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLygKDAADR 341
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  79 RDQMLLEDVLPVQedDSLMSSHPIIVTvtTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKT 158
Cdd:COG0308   342 IFVGALRSYAFAE--DAGPNAHPIRPD--DYPEIENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATT 417
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 159 SDFWAALEEASRLPVKEVMDTWTRQMGYPVLNVNGVKNiTQKRFLLDPRANPSQPpsdlgYTWNIPVK--WTEDNITSSV 236
Cdd:COG0308   418 EDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYD-ADGKVTLTLRQTPPRP-----HPFHIPLEvgLLGGKLTART 491
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863 237 LFNRSEKEGItlnssnpsgnaflKINPDHIGFYRVNYEVATWDSIATAlslnhktfsSADRASLIDDAFALARAQLLDYK 316
Cdd:COG0308   492 VLLDGEQTEL-------------VAKPDPVLLLRLDDELAFLLAHDSD---------PFNRWEALQALWRDGEADYLDAL 549
                         330
                  ....*....|...
gi 1034638863 317 VALNLTKYLKREE 329
Cdd:COG0308   550 RALADTDPAVRAE 562
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
1-183 2.13e-53

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 188.49  E-value: 2.13e-53
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYdpkESASSNQ-QRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHA--ETD-W 76
Cdd:cd09602   260 MENPGAVTFRESYLFR---EEPTRAQrLRRANTILHEMAHMWFGDLVTMKWWDDLWLNESFADFMAAKALAEAtpFTDaW 336
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  77 QmrdQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNA 156
Cdd:cd09602   337 L---TFLLRRKPWAYRADQLPTTHPIAQDVPDLEAAGSNFDGITYAKGASVLKQLVALVGEEAFRAGLREYFKKHAYGNA 413
                         170       180
                  ....*....|....*....|....*..
gi 1034638863 157 KTSDFWAALEEASRLPVKEVMDTWTRQ 183
Cdd:cd09602   414 TLDDLIAALDEASGRDLSAWADAWLRT 440
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
1-167 2.24e-50

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 179.56  E-value: 2.24e-50
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKESASSnqQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFE--FLGVNHAETDWQM 78
Cdd:cd09595   250 MENPGLITFRTTYLLRSKVTDTGA--RSIENVIAHELAHQWFGNLVTMRWWNDLWLNEGFAVYYEnrIMDATFGTSSRHL 327
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  79 rDQMLLEDVLpvQEDDSLMSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKT 158
Cdd:cd09595   328 -DQLSGSSDL--NTEQLLEDSSPTSTPVRSPADPDVAYDGVTYAKGALVLRMLEELVGEEAFDKGVQAYFNRHKFKNATT 404

                  ....*....
gi 1034638863 159 SDFWAALEE 167
Cdd:cd09595   405 DDFIDALEE 413
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
1-190 3.32e-42

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 162.65  E-value: 3.32e-42
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYREtNLLYDPKESASSNQQRVATVvAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFL------GVNHAET 74
Cdd:TIGR02412 261 MENAGCVTFAE-NFLHRAEATRAEKENRAGVI-LHEMAHMWFGDLVTMRWWNDLWLNESFAEYMGTLasaeatEYTDAWT 338
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  75 DW--QMRDQMLLEDVLPvqeddslmSSHPIIVTVTTPDEITSVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQ 152
Cdd:TIGR02412 339 TFaaQGKQWAYEADQLP--------TTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHA 410
                         170       180       190
                  ....*....|....*....|....*....|....*...
gi 1034638863 153 FKNAKTSDFWAALEEASRLPVKEVMDTWTRQMGYPVLN 190
Cdd:TIGR02412 411 FGNATLDDLIDSLAKASGRDLSAWSDAWLETAGVNTLT 448
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
1-180 2.70e-31

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 126.16  E-value: 2.70e-31
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKEsassnqqrvATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRD 80
Cdd:cd09603   248 MEHQTATTYGNNFLNGDRGS---------ERLIAHELAHQWFGDSVTCADWADIWLNEGFATYAEWLWSEHKGGADAYRA 318
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  81 QMLledvlpvQEDDSLMSSHPIIVTVTTPDEItsvFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSD 160
Cdd:cd09603   319 YLA-------GQRQDYLNADPGPGRPPDPDDL---FDRDVYQKGALVLHMLRNLLGDEAFFAALRAYLARYAHGNVTTED 388
                         170       180
                  ....*....|....*....|
gi 1034638863 161 FWAALEEASRLPVKEVMDTW 180
Cdd:cd09603   389 FIAAAEEVSGRDLTWFFDQW 408
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
1-169 2.42e-21

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 96.82  E-value: 2.42e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTM-DWWEdLWLNEGFASFfeflgvnhaetdwqmR 79
Cdd:cd09600   256 MENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCrDWFQ-LSLKEGLTVF---------------R 319
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  80 DQMLLEDVL--PVQ--------------EDDSLMSsHPIivtvtTPD---EITSVFDGISYSKGSSILRMLEDWIKPENF 140
Cdd:cd09600   320 DQEFSADMNsrAVKriedvrrlrsaqfpEDAGPMA-HPI-----RPDsyiEINNFYTVTVYEKGAEVIRMLHTLLGEEGF 393
                         170       180
                  ....*....|....*....|....*....
gi 1034638863 141 QKGCQMYLEKYQFKNAKTSDFWAALEEAS 169
Cdd:cd09600   394 RKGMDLYFERHDGQAVTCEDFVAAMEDAS 422
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
30-167 3.11e-20

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 93.68  E-value: 3.11e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  30 ATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFE------FLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPII 103
Cdd:cd09599   283 VDVIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLErrilerLYGEEYRQFEAILGWKDLQESIKEFGEDPPYTLLVPDL 362
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1034638863 104 VTVtTPDEitsVFDGISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEE 167
Cdd:cd09599   363 KGV-DPDD---AFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLE 422
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
32-180 1.79e-18

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 88.10  E-value: 1.79e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  32 VVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLmsshPIIVTVTTPDE 111
Cdd:cd09604   296 VVVHEIAHQWFYGIVGNDERREPWLDEGLATYAESLYLEEKYGKEAADELLGRRYYRAYARGPGG----PINLPLDTFPD 371
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1034638863 112 ITSVFDgISYSKGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTW 180
Cdd:cd09604   372 GSYYSN-AVYSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTAEEVSGKDLDWFFRGW 439
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
30-167 1.84e-14

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 76.35  E-value: 1.84e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  30 ATVVAHELVHQWFGNIVTMDWWEDLWLNEGFASFFE--FLGVNHAEtdwQMRDQMLLEDVLPVQEDDSLMSSHP----II 103
Cdd:TIGR02411 280 VDVIAHELAHSWSGNLVTNCSWEHFWLNEGWTVYLErrIIGRLYGE---KTRHFSALIGWGDLQESVKTLGETPeftkLV 356
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1034638863 104 VTVTT--PDEitsVFDGISYSKGSSILRMLEDWI-KPENFQKGCQMYLEKYQFKNAKTSDFWAALEE 167
Cdd:TIGR02411 357 VDLKDndPDD---AFSSVPYEKGFNFLFYLEQLLgGPAEFDPFLRHYFKKFAYKSLDTYQFKDALYE 420
pepN PRK14015
aminopeptidase N; Provisional
1-204 2.54e-13

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 73.24  E-value: 2.54e-13
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863   1 MENWGLityretNL------LYDPkESAS-SNQQRVATVVAHELVHQWFGNIVTM-DWWEdLWLNEGFASFfeflgvnha 72
Cdd:PRK14015  268 MENKGL------NIfnskyvLADP-ETATdADYERIESVIAHEYFHNWTGNRVTCrDWFQ-LSLKEGLTVF--------- 330
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034638863  73 etdwqmRDQMLLEDVL--PVQ--------------EDDSLMSsHPIivtvtTPD---EI-----TSVfdgisYSKGSSIL 128
Cdd:PRK14015  331 ------RDQEFSADLGsrAVKriedvrvlraaqfaEDAGPMA-HPV-----RPDsyiEInnfytATV-----YEKGAEVI 393
                         170       180       190       200       210       220       230
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1034638863 129 RMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMdTWTRQMGYPVLNVNGVKNITQKRFLL 204
Cdd:PRK14015  394 RMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLSQFR-RWYSQAGTPRVTVSDEYDAAAGTYTL 468
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
32-67 1.84e-06

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 46.71  E-value: 1.84e-06
                          10        20        30
                  ....*....|....*....|....*....|....*..
gi 1034638863  32 VVAHELVHQWFGNIVTMDW-WEDLWLNEGFASFFEFL 67
Cdd:cd09594    68 VLAHELTHAFTGQFSNLMYsWSSGWLNEGISDYFGGL 104
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
12-63 3.23e-04

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 43.76  E-value: 3.23e-04
                          10        20        30        40        50
                  ....*....|....*....|....*....|....*....|....*....|....
gi 1034638863  12 TNLLYDPK--ESASSNQQrvatVVAHELVHQWFGNIVTMDWWEDLWLNEGFASF 63
Cdd:cd09839   359 SRLLYPPDiiDQAYETRR----KLAHALASQWFGINIIPKTWSDTWLVIGIAGY 408
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH